Determination of Ownership Sample Clauses

Determination of Ownership. In determining ownership of Company Common Stock hereunder for any purpose, the Company may rely solely on the records of the transfer agent for the Company Common Stock from time to time, or, if no such transfer agent exists, the Company’s stock ledger.

Determination of Ownership. In the event of any disagreement between Persons claiming to be Transferees of any Trust Unit, or in the event of any question on the part of the Trustee when presented with a request for transfer of a Trust Unit, which the Trustee believes is not fully resolved by opinions of counsel or other documents obtained in connection therewith, then, in addition to other rights which it may have under applicable law, the Trustee shall be entitled at its option to refuse to recognize any such claim so long as such disagreement or question shall continue. In so refusing, the Trustee, and any Entity serving in such capacity, may elect to refrain or refuse to act with respect to the interest represented by the Trust Unit involved, or any part thereof, or of any sum or sums of money accrued or accruing thereunder, and, in so doing, the Trustee shall not be or become liable to any Person for the failure or refusal of the Trustee to comply with such conflicting claims or requests for transfer, and shall be entitled to continue so to refrain and refuse so to act, until: (a) the rights of the adverse claimants or the questions of the Trustee have been adjudicated by a final nonappealable judgment of a court assuming and having jurisdiction of the parties and the interest and money involved; or (b) all differences have been adjusted by valid agreement between said parties and the Trustee shall have been notified thereof in writing signed by all of the interested parties.

Determination of Ownership. In the event of any disagreement between Persons claiming to be Transferees of any Trust Unit, or in the event of any question on the part of the Trustee when presented with a request for transfer of a Trust Unit, that the Trustee believes is not fully resolved by opinions of counsel or other documents obtained in connection therewith, then, in addition to other rights that it may have under applicable law, the Trustee shall be entitled at its option to refuse to recognize any such claim so long as such disagreement or question shall continue. In so refusing, the Trustee may elect to refrain or refuse to act with respect to the interest represented by the Trust Unit involved, or any part thereof, or of any sum or sums of money accrued or accruing thereunder, and, in so doing, the Trustee shall not be or become liable to any Person for the failure or refusal of the Trustee to comply with such conflicting claims or requests for transfer, and shall be entitled to continue so to refrain and refuse so to act, until: (a) the rights of the adverse claimants or the questions of the Trustee have been adjudicated by a final nonappealable judgment of a court assuming and having jurisdiction of the parties and the interest and money involved, or (b) all differences have been resolved by valid agreement between said parties and the Trustee shall have been notified thereof in writing signed by all of the interested parties.

Determination of Ownership. Inventions and ownership of intellectual property resulting from the research will be determined by U.S. patent law. NINDS Materials were developed by Lonza under contract for the NIH. While NINDS places no restriction on development of commercial products resulting from the knowledge gained from research using the NINDS Materials. The iPS Academia Japan, Inc. (“iPS AJ”), in addition to other third parties, own patents that may cover certain of the NINDS Materials. iPS AJ can be contacted at ▇▇▇▇://▇▇▇-▇▇▇▇.▇▇▇/e/license/policy.html to discuss obtaining a commercial license. The NHCDR cannot provide a warranty or any assurances whatsoever relating to third-party property interests that may exist in the NINDS Materials. The attached Appendix A, “Notification to Recipient,” is incorporated fully into this MTA as required by Lonza’s license with iPS AJ and cannot be further modified. The Principal Investigator and the Institution will be responsible for adhering to the terms and conditions in Appendix A as well as those in the MTA. The terms and conditions attached hereto as Appendix A shall take precedence over any contrary or inconsistent terms and conditions appearing or referred to in this MTA. Unless instructed otherwise by NHCDR, Principal Investigator must provide a report within five (5) years of receipt of the NINDS Materials or upon completion of research described under the SRI, whichever is shorter. Within six (6) months after the completion of the SRI using the NINDS Materials, Principal Investigator must email ▇▇▇▇▇@▇▇▇.▇▇▇▇▇▇▇.▇▇▇ a final report including: (i) a brief summary of the research results or outcome of the project; (ii) a list of related publications or presentations; and (iii) a statement attesting destruction of the NINDS Materials. Principal Investigator should include his/her current contact information in the final report should follow up be required. Principal Investigator must acknowledge the NHCDR and the NINDS Materials identification number in any publications or presentations based on research utilizing the NINDS Materials. Additionally, the following acknowledgement statement must be included in all publications, “Generation of the GMP line LiPSC-GR1.1 was supported by the NIH Common Fund Regenerative Medicine Program, and reported in Stem Cell Reports. The NIH Common Fund and the National Center for Advancing Translational Sciences (NCATS) are joint stewards of the LiPSC-GR1.1 resource.”

Determination of Ownership. From time to time, at the request of the Company, each Shareholder will confirm in writing that it continues to Beneficially Own Registrable Securities. The rights of a Shareholder under this Agreement shall terminate when such Shareholder no longer owns Registrable Securities and this Agreement shall terminate when no Shareholder owns Registrable Securities.

Determination of Ownership. Ownership of all inventions constituting Study Intellectual Property will follow inventorship as determined under applicable law, subject to any assignment of rights by an inventor to his or her employer or pursuant to written contract. Ownership of all works of authorship and software constituting Study Intellectual Property will follow authorship as determined under applicable law subject to the “work for hire” doctrine and any assignment of rights by an author to his or her employer or pursuant to written contract. Ownership of all other intellectual property (e.g., know-how) will be determined under applicable law, subject to any assignment of rights to his or her employer or pursuant to written contract. Each party, represents, warrants and agrees that unless otherwise agreed in writing by the other party, it will not allow any officer, director, employee, consultant, contractor, scientific advisory board member, member of its faculty or scientific staff, student or other person to participate in the design, conduct, or analysis of a Clinical Study on its behalf unless such person has agreed to assign to that party any inventions, discoveries, or other intellectual property that such person may generate in connection with such work.

Determination of Ownership. (a) The Committee will determine whether the potentially patentable property is owned by the University, by the employee(s), by an outside sponsor, or jointly by some combination of these. (b) Under the federal patent and trademark legislation of 1980 (35 U.S.C. 200 et seq.), the University has the right of first refusal to title in inventions made in the performance of federal grants and contracts. The University will assert title to and attempt to license inventions made with federal government funds so that the Congressional purpose of fostering the development of industry in the United States will be furthered.

Determination of Ownership. In determining ownership of Second Lien Notes hereunder for any purpose, the Company may rely solely on the records of the registrar or Indenture trustee for the Second Lien Notes from time to time, or, if no such registrar or Indenture trustee exists, the Company’s ledger.

Determination of Ownership. 10 6.2 In Force Dates...................................... 11 6.3